Digest Network Come funziona
Network
/
Società
An
Non verificato

Anebulo Pharmaceuticals, Inc.

Di cosa scriviamo

FarmaceuticaMaterie primeMedicina - VarieMercato azionarioSalute

11 comunicati stampa

Guarda tutti i comunicati
13/11/2025
Salute
Farmaceutica
Mercato azionario
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent Updates
Fonte
Anebulo Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
29/09/2025
Finanza
Igiene alimentare
Medicina - Varie
Associazioni/Professionisti
Sanità
Farmaceutica
Salute
Materie prime
Mercato azionario
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Recent Updates
Fonte
Anebulo Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
25/09/2025
Industria
Biotecnologia
Materie prime
Farmaceutica
Finanza
Salute
Associazioni/Professionisti
Medicina - Varie
Anebulo Pharmaceuticals Announces First Patients Dosed in Phase 1 Single Ascending Dose Study of Intravenous Selonabant, under Development for Acute Cannabis-Induced Toxicity
Fonte
Anebulo Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
12/09/2025
Biotecnologia
Materie prime
Farmaceutica
Salute
Medicina - Varie
Sanità
Anebulo Pharmaceuticals Announces Update on Going Private Transaction and Strategic Alternatives
Fonte
Anebulo Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
23/07/2025
Farmaceutica
Salute
Materie prime
Anebulo Pharmaceuticals Approves Plan to Terminate Registration of Its Common Stock
Fonte
Anebulo Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
13/05/2025
Mercato azionario
Associazioni/Professionisti
Salute
Sanità
Finanza
Farmaceutica
Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Updates
Fonte
Anebulo Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
14/02/2025
Salute
Farmaceutica
Mercato azionario
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2025 Financial Results and Recent Updates
Fonte
Anebulo Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
23/12/2024
Industria
Salute
Igiene alimentare
Materie prime
Medicina - Varie
Farmaceutica
Biotecnologia
Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise
Fonte
Anebulo Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
13/11/2024
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Mercato azionario
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent Updates
Fonte
Anebulo Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
25/09/2024
Mercato azionario
Associazioni/Professionisti
Salute
Sanità
Finanza
Medicina - Varie
Farmaceutica
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent Updates
Fonte
Anebulo Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0